The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.
Effective Management of Internal Stakeholders and External Strategic Partners from Multiple Perspectives: Non-Profit, CRO, and Pharmaceutical Industry
Jing Li, MBA, MS, PMP
Head of Program Management Office
Castle Creek Pharmaceuticals, United States
Drug development has become an increasingly complex process due to rising costs, increased regulations, and the need to collaborate with essential internal and external stakeholders. Companies are embracing strategies to mitigate the risks of these costly and time sensitive development programs. This has resulted in an increasing number of companies in-licensing products and outsourcing development activities. Therefore, effective stakeholder management is an essential component of any successful drug development project. This forum will include three panelists who are experts in managing the collaborations and strategies for the biotech/pharmaceutical drug development process. This includes stakeholders such as business partners, non-profit consortiums, academia, key opinion leaders, and patient advocacy groups. Panelists will share their experiences and through case studies demonstrate some of the challenges they face in their individual unique settings. These challenges include how each business segment (advocacy, CRO, and medical affairs), define key stakeholders and how they developed plans to manage expectations and achieve project goals within set timeline and budget parameters.
Learning Objective : Define stakeholders and recognize different levels of stakeholders; Identify key stakeholders and stakeholders in various settings from different perspectives; Recognize the similarities and differences of stakeholders in different settings; Identify risks and mitigation strategies; Develop a stakeholder management plan.
Stakeholder Management: From Non-Profit and Industry/Academic/Government Consortium